Myocardial iron deposition in β-Thalassemia studied by magnetic resonance imaging

被引:32
作者
Mavrogeni, SI
Maris, T
Gouliamos, A
Vlahos, L
Kremastinos, DT
机构
[1] Onassis Cardiac Surg Ctr, Athens, Greece
[2] Areteion Hosp, Athens, Greece
来源
INTERNATIONAL JOURNAL OF CARDIAC IMAGING | 1998年 / 14卷 / 02期
关键词
beta-thalassemia; heart; iron overload; MRI;
D O I
10.1023/A:1005922016048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial iron deposition is a common finding in beta-thalassemia. The iron content of the myocardium was assessed using the T2 relaxation time of the heart. The T2 relaxation time of the liver and skeletal muscle was also assessed in order to study the relation of iron deposition between heart, liver and skeletal muscle. ECG gated spin echo images were obtained from thirty-eight consecutive adult thalassemic patients examined in an outpatient clinic, aged (x+/-SD) 25+/-6 years, using a 0.5 T system. Patients were divided into groups A and B, according to their average serum ferritin levels of the preceding five years (> or < 2000 ng/ml). Results were compared with nine controls, aged 24+/-7 years. Heart T2 relaxation time in the control group (x+/-SD)(48.3+/-5.5 msec) was higher compared to group A (28.4+/-6.7 msec, p<0.001) but not to group B (43.4+/-7.4 msec). The T2 relaxation time of the heart correlated positively with the T2 relaxation time of the liver (r=0.68, p<0.001) and negatively with ferritin levels (r=-0.67, p<0.001). There was no correlation with the T2 relaxation time of skeletal muscle. This study indicates that regularly transfused beta-thalassemia patients may present with a broad variation of heart iron deposition which, however, is related to serum ferritin levels.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 28 条
[11]  
ISSELBACHER, 1994, HARRISONS PRINCIPLES, P1741
[12]   FERRITIN IN SERUM OF NORMAL SUBJECTS AND PATIENTS WITH IRON-DEFICIENCY AND IRON OVERLOAD [J].
JACOBS, A ;
WARDROP, CA ;
WORWOOD, M ;
BEAMISH, MR ;
MILLER, F .
BRITISH MEDICAL JOURNAL, 1972, 4 (5834) :206-&
[13]  
Jacobs A, 1980, IRON BIOCH MED, VII, P439
[14]  
JOHNSTON DL, 1989, AM J MED, V87, P40
[15]   GROWTH OF CHILDREN WITH THALASSAEMIA - EFFECT OF DIFFERENT TRANSFUSION REGIMENS [J].
KATTAMIS, C ;
TOULIATOS, N ;
HAIDAS, S ;
MATSANIOTIS, N .
ARCHIVES OF DISEASE IN CHILDHOOD, 1970, 45 (242) :502-+
[16]   MYOCARDITIS IN BETA-THALASSEMIA MAJOR - A CAUSE OF HEART-FAILURE [J].
KREMASTINOS, DT ;
TINIAKOS, G ;
THEODORAKIS, GN ;
KATRITSIS, DG ;
TOUTOUZAS, PK .
CIRCULATION, 1995, 91 (01) :66-71
[17]  
LIU P, 1992, Journal of the American College of Cardiology, V19, p187A
[18]  
Liu Peter, 1993, Journal of the American College of Cardiology, V21, p409A
[19]   COMPUTED-TOMOGRAPHY SCANNING OF THE LIVER TO DETERMINE EFFICACY OF IRON CHELATION-THERAPY IN THALASSEMIA MAJOR [J].
OLIVIERI, NF ;
GRISARU, D ;
DANEMAN, A ;
MARTIN, DJ ;
ROSE, V ;
FREEDMAN, MH .
JOURNAL OF PEDIATRICS, 1989, 114 (03) :427-430
[20]   SURVIVAL IN MEDICALLY TREATED PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA [J].
OLIVIERI, NF ;
NATHAN, DG ;
MACMILLAN, JH ;
WAYNE, AS ;
LIU, PP ;
MCGEE, A ;
MARTIN, M ;
KOREN, G ;
COHEN, AR .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) :574-578